Research Group Lung Cancer
1 – 10 of 144
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Dynamic assessment of proliferation to guide response-adapted therapy in the setting of neoadjuvant chemotherapy in ER+/HER2- breast cancer
- Contribution to journal › Article
-
Mark
Tumour acidosis remodels the glycocalyx to control lipid scavenging and ferroptosis
(2026) In Nature Cell Biology
- Contribution to journal › Article
-
Mark
Homologous recombination deficiency in primary ER-positive and HER2-negative breast cancer
- Contribution to journal › Article
-
Mark
Multiomics assessment of lung adenocarcinoma subtypes defined through tumor purity-adjusted DNA methylation
- Contribution to journal › Article
-
Mark
Tumor microenvironment transcriptional activity enables robust stratification of chemotherapy response in triple-negative breast cancer
- Contribution to journal › Article
- 2025
-
Mark
A two-phase epigenome-wide four-way gene–smoking interaction study of overall survival for early-stage non-small cell lung cancer
- Contribution to journal › Article
-
Mark
Immune Response in Triple-Negative Breast Cancer - Machine Learning-based Insights from Histology and -Omics
(2025) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
Intrathecal pemetrexed for leptomeningeal metastases in a patient with ALK-rearranged lung adenocarcinoma : a case report
- Contribution to journal › Article
-
Mark
Multi-omic profiling of squamous cell lung cancer identifies metabolites and related genes associated with squamous cell carcinoma
- Contribution to journal › Article
-
Mark
Stand-alone transcriptional immune response prediction in primary triple-negative breast cancer
- Contribution to journal › Article
